Skip to main content
Ichinomiya city on Muck Rack

Ichinomiya city

As seen in: Color Research & Application
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ichinomiya

Contact Ichinomiya, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab - Scientific Reports

|
By Ichinomiya city, Kobe City, Hirakata City, Himeji City
| link.springer.com
Abstract Taxane plus ramucirumab (RAM) is the standard second-line treatment for advanced gastric cancer (AGC). However, data on second-line therapy following first-line treatment with nivolumab remains limited. This study aimed to evaluate the efficacy, safety, and prognostic factors of taxane plus RAM in patients with advanced AGC who previously received chemotherapy plus nivolumab.
Open in Who Shared View Duplicates (2) Issue with article?

Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective randomized controlled pilot study - Shibuya - 2017 - Diabetes, Obesity and Metabolism - Wiley Online Libra

|
By Aza Hira, Ichinomiya city, Internal Medcine
| Color Research & Application Verified
AbstractNon-alcoholic fatty liver disease (NAFLD) often coexists with type 2 diabetes (T2D), and its prevalence in patients with T2D is estimated to be approximately 50%–60% in Japan.1 In some patients with T2D, NAFLD can progress to non-alcoholic steatohepatitis?(NASH) and further to liver cirrhosis and hepatocellular carcinoma (HCC).2 Moreover, NAFLD is considered an independent risk factor for cardiovascular events.3
Open in Who Shared Issue with article?
See all 2 articles